Basic Information
RNALocate ID: | RLID:11004137 |
RNA Symbol: | hsa-miR-744-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-744-5p |
RNA ID: | miRBase:MIMAT0004945 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 24460325 |
Tissue/Cell Line: | K562 cells |
Method: | Microarray |
Description: | Cluster analysis arranged samples and miRNAs into groups based on their expression levels, which allowed us to hypothesize the relationships between miRNAs and samples. Interestingly, 49 miRNAs were up regulated in exosomes as compared to K562 cells (Table 1), with both P-value of <= 0.05 and more than 1.5-fold changes. Data are collected from Table 1. Differentially Expressed miRNAs Between Exosomes and K562 Cells. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002696 | Cytoplasm | Neural progenitor cells | 21363885 |
RLID:01002697 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002698 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002699 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002700 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11004134 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11004135 | Exosome | Plasma | 23663360 |
RLID:11004136 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11004138 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11004139 | Microvesicle | Plasma | 23077538 |
RLID:11004140 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000216 | Exosome | Blood|Endothelial cells | |
RLID-D:11000721 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-744-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-68635 |
MNDR | hsa-miR-744-5p | Lymphoma | MNDR-E-MI-68636 |
MNDR | hsa-miR-744-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-68637 |
MNDR | hsa-miR-744-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-68638 |
MNDR | hsa-miR-744-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-68639 |
MNDR | hsa-miR-744-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-68640 |
MNDR | hsa-miR-744-5p | Her2-receptor positive breast cancer | MNDR-E-MI-68641 |
MNDR | hsa-miR-744-5p | Breast cancer luminal | MNDR-E-MI-68642 |
MNDR | hsa-miR-744-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-68643 |
MNDR | hsa-miR-744-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-68644 |
MNDR | hsa-miR-744-5p | Gastric cancer | MNDR-E-MI-68645 |
MNDR | hsa-miR-744-5p | Alzheimer disease | MNDR-E-MI-68646 |
MNDR | hsa-miR-744-5p | Bladder cancer | MNDR-E-MI-68647 |
MNDR | hsa-miR-744-5p | Dysautonomia familial | MNDR-E-MI-68648 |
MNDR | hsa-miR-744-5p | Leukemia | MNDR-E-MI-68649 |
MNDR | hsa-miR-744-5p | Cardiovascular disease | MNDR-E-MI-68650 |
MNDR | hsa-miR-744-5p | Carotid stenosis | MNDR-E-MI-68651 |
MNDR | hsa-miR-744-5p | Lung cancer | MNDR-E-MI-68652 |
MNDR | hsa-miR-744-5p | Parkinson disease | MNDR-E-MI-68653 |
MNDR | hsa-miR-744-5p | Basal-like breast cancer | MNDR-E-MI-68654 |
MNDR | hsa-miR-744-5p | Pituitary neoplasms | MNDR-E-MI-68655 |
MNDR | hsa-miR-744-5p | Pancreatic cancer | MNDR-E-MI-68656 |
MNDR | hsa-miR-744-5p | Williams syndrome | MNDR-E-MI-68657 |
MNDR | hsa-miR-744-5p | Rectum adenocarcinoma | MNDR-E-MI-68658 |
MNDR | hsa-miR-744-5p | Colon cancer | MNDR-E-MI-68659 |
MNDR | hsa-miR-744-5p | Colon adenocarcinoma | MNDR-E-MI-68660 |
MNDR | hsa-miR-744-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-68661 |
MNDR | hsa-miR-744-5p | Acromegaly | MNDR-E-MI-68662 |
MNDR | hsa-miR-744-5p | Glioblastoma | MNDR-E-MI-68663 |
MNDR | hsa-miR-744-5p | Glioma | MNDR-E-MI-68664 |
MNDR | hsa-miR-744-5p | Chordoma | MNDR-E-MI-68665 |
MNDR | hsa-miR-744-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-68666 |
MNDR | hsa-miR-744-5p | Osteosarcoma | MNDR-E-MI-68667 |
MNDR | hsa-miR-744-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-68668 |
MNDR | hsa-miR-744-5p | Liver cancer | MNDR-E-MI-68669 |
MNDR | hsa-miR-744-5p | Gastric adenocarcinoma | MNDR-E-MI-68670 |
MNDR | hsa-miR-744-5p | Pituitary adenoma | MNDR-E-MI-68671 |
MNDR | hsa-miR-744-5p | Lung adenocarcinoma | MNDR-E-MI-68672 |
MNDR | hsa-miR-744-5p | Thyroid carcinoma | MNDR-E-MI-68673 |
MNDR | hsa-miR-744-5p | Pancreatic adenocarcinoma | MNDR-E-MI-68674 |
MNDR | hsa-miR-744-5p | Carcinoma renal cell | MNDR-E-MI-68675 |
MNDR | hsa-miR-744-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-68676 |
MNDR | hsa-miR-744-5p | Clear cell renal cell carcinoma | MNDR-E-MI-68677 |
MNDR | hsa-miR-744-5p | Biliary tract cancer | MNDR-E-MI-68678 |
MNDR | hsa-miR-744-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-68679 |
MNDR | hsa-miR-744-5p | Esophageal cancer | MNDR-E-MI-68680 |
MNDR | hsa-miR-744-5p | T acute lymphoblastic leukemia | MNDR-E-MI-68681 |
MNDR | hsa-miR-744-5p | Acute t cell leukemia | MNDR-E-MI-68682 |
MNDR | hsa-miR-744-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-68683 |
MNDR | hsa-miR-744-5p | Fibromyalgia | MNDR-E-MI-68684 |
MNDR | hsa-miR-744-5p | Adenoma | MNDR-E-MI-68685 |
MNDR | hsa-miR-744-5p | Hepatocellular carcinoma | MNDR-E-MI-68686 |
MNDR | hsa-miR-744-5p | Rheumatoid arthritis | MNDR-E-MI-68687 |
MNDR | hsa-miR-744-5p | Barrett's adenocarcinoma | MNDR-E-MI-68688 |
MNDR | hsa-miR-744-5p | Hodgkin lymphoma | MNDR-E-MI-68689 |
MNDR | hsa-miR-744-5p | Neuromyelitis optica | MNDR-E-MI-68690 |
MNDR | hsa-miR-744-5p | Colorectal cancer | MNDR-E-MI-68691 |
MNDR | hsa-miR-744-5p | Nasopharynx carcinoma | MNDR-E-MI-68692 |
MNDR | hsa-miR-744-5p | Multiple myeloma | MNDR-E-MI-68693 |
MNDR | hsa-miR-744-5p | Nasopharyngeal cancer | MNDR-E-MI-68694 |
MNDR | hsa-miR-744-5p | Epstein-barr virus infections | MNDR-E-MI-68695 |
MNDR | hsa-miR-744-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-68696 |
MNDR | hsa-miR-744-5p | Stroke lacunar | MNDR-E-MI-68697 |
MNDR | hsa-miR-744-5p | Barrett's carcinogenesis | MNDR-E-MI-68698 |
MNDR | hsa-miR-744-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-68699 |
MNDR | hsa-miR-744-5p | Tubulovillous adenoma | MNDR-E-MI-68700 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ARHGAP5 | Homo sapiens | RR00122473 |
TOP